MD NOUSHAD JAVED

Employment

• The University of Texas Rio Grande Valley
  2022 - Present
• KR Mangalam University
  2021 - 2022
• Jamia Hamdard
• Jamia Millia Islamia
• Apeejay Stya University Assistant Professor

Education

• Indian Institute of Technology Delhi Six Sigma
  2016 - Present
• Annamalai University Post graduate Business management
  2014 - 2015
• Jamia Hamdard Faculty of Pharmacy Ph.D
  2013 - Present
• World Intellectual Property Organization General Course on Intellectual Property
  2013 - 2014
• Annamalai University Post graduate Software based statistical analysis
  2013 - 2014
• Jamia Hamdard M.Pharma (Pharmaceutics)
  2011 - 2013
• Annamalai University Post graduate Advanced validation science
  2011 - 2012
• Annamalai University Post graduate Regulatory affair
  2010 - 2011
• Jamia Hamdard B.Pharma
  2007 - 2011
• Aligarh Muslim University SSSC
  2003 - 2005
• Jamia Hamdard PhD

Projects & Funding

Projects & funding information is unavailable.

Publications (75)

• Current Challenges Against Lung Cancer Therapy
  Lung Cancer Overview and Therapies 2026 DOI: 10.1201/9781779640239-6
  +Save
• Emerging Techniques in Drug Repurposing: Uncovering Novel Treatment Options
  CNS and Neurological Disorders Drug Targets 2026 DOI: 10.2174/0118715273448179251121152910
  +Save
• Abstract B040: Bridging epigenetic mechanisms in brain cancer: A perspective on the interventions of creative arts therapy on patient outcomes
  Cancer Research 2026 DOI: 10.1158/1538-7445.RARECA26-B040
  +Save
• 3D Organoid-Based Therapeutics with Translational Potential in Cancer Immunity and Autoimmune Risk Prediction
  CANCER IMMUNOLOGY RESEARCH 2025 DOI: 10.1158/2326-6074.CIMM25-B015
  +Save
• Advanced therapeutic analysis of undruggable oncoprotein KRAS; 3D structural and functional significance by I-TASSER
  CANCER RESEARCH 2025 DOI: 10.1158/1538-7445.CANEVOL25-B031
  +Save
• Artificial intelligence applications in cancer care: Algorithmic bias impacts health equity
  CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2025 DOI: 10.1158/1538-7755.DISP25-A070
  +Save
• Artificial intelligence in cancer patient care-associated challenges in United States of America
  CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2025 DOI: 10.1158/1538-7755.DISP25-A071
  +Save
• Chimeric antigen receptor (CAR-T) cell therapy in ovarian cancer: Challenges and strategies for overcoming therapeutic barriers
  CANCER RESEARCH 2025 DOI: 10.1158/1538-7445.OVARIAN25-A065
  +Save
• Gen-Z AI health access: A decentralized, ethical artificial intelligence platform for global cancer care in remote communities
  CANCER RESEARCH 2025 DOI: 10.1158/1538-7445.CANEVOL25-A029
  +Save
• Nanocarrier-mediated siRNA delivery to boost CAR-T cell therapy in tumor microenvironment-driven immune dysregulation in ovarian cancer
  CANCER RESEARCH 2025 DOI: 10.1158/1538-7445.OVARIAN25-A064
  +Save